CIK 0001850119 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 109.2 M | 2.2 M | 5.2 M |
| Net income (USD) | -9.6 M | -136.7 M | -130.9 M |
| Diluted EPS (USD/shares) | -0.14 | -2.3 | -2.96 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 8-K | FORM 8-K items 7.01,8.01,9.01 | 2026-10-02 |
| 2026-09-15 | 4 | 4 | 2026-09-14 |
| 2026-09-15 | 4 | 4 | 2026-09-14 |
| 2026-09-15 | 4 | 4 | 2026-09-11 |
| 2026-09-14 | 144 | 144 | |
| 2026-09-14 | 144 | 144 | |
| 2026-09-10 | 4 | 4 | 2026-09-09 |
| 2026-09-10 | 3 | 3 | 2026-09-09 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-09-09 | 4 | 4 | 2026-09-08 |
| 2026-09-09 | 4 | 4 | 2026-09-08 |
| 2026-09-09 | 8-K | FORM 8-K items 5.02,7.01,9.01 | 2026-09-09 |
| 2026-09-08 | 144 | 144 | |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-12 | 8-K | FORM 8-K items 2.02,7.01,9.01 | 2026-08-12 |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-06-16 | 8-K | FORM 8-K items 5.02 | 2026-06-15 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-12 | 4 | 4 | 2026-06-11 |
| 2026-06-12 | 4 | 4 | 2026-06-11 |
| 2026-06-12 | 4 | 4 | 2026-06-11 |
Forms on file (last 1,000): 4 162, 8-K 74, 144 50, 3 25, 10-Q 16, SC 13G/A 10, CORRESP 9, SC 13G 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IPSC (0.002 USD), /gw/filings/filings?ticker=IPSC&form=8-K, /gw/filings/facts?ticker=IPSC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange